Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 702.98

-3.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (2301)	2/13/2018 12:38:43 PM
From: Biotech Jim	Read Replies (1) of 3559

A few years too late into oncology targets beyond VEGF. Where are the bi-specifics so immaculate? RGC is a long shot for any nearer term gain. Who will be the brains to capture genetic value in the longer term? One of the best companies in the world to work for, the survey says. (That always works in a rising stock price environment when stock options are involved. As at AMGN, lots of molecular miliionaires have been minted.) I have been selling my REGN shares, pissing and moaning all the way. There is a lesson to be learned here, but I might be too stubborn. I still hold shares, but is not my top biotech holding.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next